Matches in SemOpenAlex for { <https://semopenalex.org/work/W2013125957> ?p ?o ?g. }
- W2013125957 endingPage "1199" @default.
- W2013125957 startingPage "1193" @default.
- W2013125957 abstract "Duloxetine (DLX) is a dual serotonin and norepinephrine reuptake inhibitor that has been recently approved for the treatment of major depressive disorder (MDD). However, little is known about the relationship between DLX plasma levels and clinical response. The aims of this open-label study were 1) to assess clinical outcome and tolerability of DLX by means of clinician and patient assessments and 2) to evaluate the value of plasma DLX levels as predictors of clinical response and tolerability. This was a naturalistic, open-label study of 45 outpatients affected with MDD (16 men and 29 women), who received DLX at doses of 30—120 mg/day and were evaluated at baseline (T0) and after 2, 4 and 12 weeks (T1—3). The assessments included the Hamilton Rating Scales for Depression (HRSD) and Anxiety (HRSA), Clinical Global Impression-Severity (CGI-S), Beck’s Depression Inventory (BDI) and a mood visual analogue scale (VAS). Compared with T0, there were significant improvements in HRSD at T1, T2 and T3 (P < 0.001), in HRSA, CGI-S and the self-administered BDI at T2 and T3 (P < 0.001), and in the VAS scores shown at T3 (P = 0.01). DLX treatment was safe and well tolerated. Plasma DLX levels at T2 ranged from 5 to 135 ng/mL (mean ± SD = 53.56 ± 39.45) and correlated almost significantly with the DLX dose (r = 0.35; P = 0.069). There was a significant curvilinear quadratic relationship between the improvement of HRSA scores and plasma DLX levels (R 2 = 0.27; P = 0.02). The incidence of anxiety or irritability was associated with the highest plasma levels. Our findings suggest that monitoring plasma DLX levels may be helpful in predicting better treatment responses and tolerability. The present data seem to suggest an optimal anxiolytic efficacy of DLX at intermediate plasma levels." @default.
- W2013125957 created "2016-06-24" @default.
- W2013125957 creator A5000370407 @default.
- W2013125957 creator A5015648879 @default.
- W2013125957 creator A5018977541 @default.
- W2013125957 creator A5030097532 @default.
- W2013125957 creator A5037756012 @default.
- W2013125957 creator A5056784482 @default.
- W2013125957 creator A5067398265 @default.
- W2013125957 creator A5072668978 @default.
- W2013125957 creator A5019676023 @default.
- W2013125957 date "2009-04-30" @default.
- W2013125957 modified "2023-10-04" @default.
- W2013125957 title "Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels" @default.
- W2013125957 cites W144519733 @default.
- W2013125957 cites W1756167277 @default.
- W2013125957 cites W1964022439 @default.
- W2013125957 cites W1971393265 @default.
- W2013125957 cites W1973239436 @default.
- W2013125957 cites W1974622200 @default.
- W2013125957 cites W1977927738 @default.
- W2013125957 cites W1979917573 @default.
- W2013125957 cites W1982112913 @default.
- W2013125957 cites W1982721912 @default.
- W2013125957 cites W1989915234 @default.
- W2013125957 cites W1995650316 @default.
- W2013125957 cites W2000957266 @default.
- W2013125957 cites W2003363634 @default.
- W2013125957 cites W2018425549 @default.
- W2013125957 cites W2018861453 @default.
- W2013125957 cites W2028721404 @default.
- W2013125957 cites W2047902057 @default.
- W2013125957 cites W2054186137 @default.
- W2013125957 cites W2067495470 @default.
- W2013125957 cites W2069090735 @default.
- W2013125957 cites W2070835675 @default.
- W2013125957 cites W2072772870 @default.
- W2013125957 cites W2084168719 @default.
- W2013125957 cites W2094623220 @default.
- W2013125957 cites W2114613490 @default.
- W2013125957 cites W2118309105 @default.
- W2013125957 cites W2124133772 @default.
- W2013125957 cites W2135391183 @default.
- W2013125957 cites W2136918217 @default.
- W2013125957 cites W2148875560 @default.
- W2013125957 cites W2159484656 @default.
- W2013125957 cites W2160070901 @default.
- W2013125957 cites W2167845443 @default.
- W2013125957 cites W2235189311 @default.
- W2013125957 cites W51209413 @default.
- W2013125957 doi "https://doi.org/10.1177/0269881109104863" @default.
- W2013125957 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19406851" @default.
- W2013125957 hasPublicationYear "2009" @default.
- W2013125957 type Work @default.
- W2013125957 sameAs 2013125957 @default.
- W2013125957 citedByCount "12" @default.
- W2013125957 countsByYear W20131259572012 @default.
- W2013125957 countsByYear W20131259572014 @default.
- W2013125957 countsByYear W20131259572015 @default.
- W2013125957 countsByYear W20131259572016 @default.
- W2013125957 countsByYear W20131259572019 @default.
- W2013125957 countsByYear W20131259572020 @default.
- W2013125957 countsByYear W20131259572021 @default.
- W2013125957 countsByYear W20131259572023 @default.
- W2013125957 crossrefType "journal-article" @default.
- W2013125957 hasAuthorship W2013125957A5000370407 @default.
- W2013125957 hasAuthorship W2013125957A5015648879 @default.
- W2013125957 hasAuthorship W2013125957A5018977541 @default.
- W2013125957 hasAuthorship W2013125957A5019676023 @default.
- W2013125957 hasAuthorship W2013125957A5030097532 @default.
- W2013125957 hasAuthorship W2013125957A5037756012 @default.
- W2013125957 hasAuthorship W2013125957A5056784482 @default.
- W2013125957 hasAuthorship W2013125957A5067398265 @default.
- W2013125957 hasAuthorship W2013125957A5072668978 @default.
- W2013125957 hasConcept C118552586 @default.
- W2013125957 hasConcept C126322002 @default.
- W2013125957 hasConcept C138496976 @default.
- W2013125957 hasConcept C142724271 @default.
- W2013125957 hasConcept C15744967 @default.
- W2013125957 hasConcept C197934379 @default.
- W2013125957 hasConcept C204787440 @default.
- W2013125957 hasConcept C27081682 @default.
- W2013125957 hasConcept C2776000289 @default.
- W2013125957 hasConcept C2776466505 @default.
- W2013125957 hasConcept C2777353892 @default.
- W2013125957 hasConcept C2778375690 @default.
- W2013125957 hasConcept C2779177272 @default.
- W2013125957 hasConcept C2779631380 @default.
- W2013125957 hasConcept C2780051608 @default.
- W2013125957 hasConcept C2780733359 @default.
- W2013125957 hasConcept C2780764818 @default.
- W2013125957 hasConcept C2910564767 @default.
- W2013125957 hasConcept C31487548 @default.
- W2013125957 hasConcept C558461103 @default.
- W2013125957 hasConcept C71924100 @default.
- W2013125957 hasConcept C83849319 @default.
- W2013125957 hasConceptScore W2013125957C118552586 @default.
- W2013125957 hasConceptScore W2013125957C126322002 @default.